Table 2.
Unadjusted Analysis of Time to ProteaseInhibitor Initiation
Factor | HazardRatio | 95% CI |
---|---|---|
CD4 cell count before elevated viral load | ||
<200* | 1.00 | — |
200–500 | 2.38 | 1.59, 3.57 |
>500 | 8.33 | 2.63, 25.0 |
History of AIDS-defining diagnosis | 0.24 | 0.15, 0.36 |
History of pneumocystis pneumonia | 0.32 | 0.21, 0.49 |
Tenfold increase in initial elevated viral load | 0.43 | 0.31, 0.59 |
Known to be HIV positive <6 years | 1.05 | 0.75, 1.49 |
Female | 1.30 | 0.76, 2.22 |
HIV risk factor | ||
Unprotected homosexual male contact | 0.77 | 0.50, 1.19 |
Injection drug use | 2.08 | 1.05, 4.17 |
Heterosexual contact or transfusion | 1.41 | 0.85, 2.33 |
History of anxiety | 1.06 | 0.67, 1.61 |
History of depression | 1.28 | 0.91, 1.79 |
Private insurance | 1.31 | 0.93, 1.85 |
Number of viral load checks (total)† | 0.86 | 0.80, 0.93 |
Number of infectious disease consultant visits†‡ | 1.15 | 0.60, 21.7 |
Number of RN and MD visits in past year† | 0.94 | 0.91, 0.97 |
Low-volume physician (<4 patients with HIV) | 1.15 | 0.78, 1.69 |
Faculty physician | 0.88 | 0.59, 1.30 |
Involvement in clinical trial in past year | 0.70 | 0.48, 1.02 |
Referent group.
Per one unit increase.
Time-varying covariate.